Works matching IS 00015555 AND DT 2020 AND VI 100 AND IP 12


Results: 11
    1
    2
    3
    4
    5
    6
    7

    Health Economic Consequences of a Tightly Controlled Dose Reduction Strategy for Adalimumab, Etanercept and Ustekinumab Compared with Standard Psoriasis Care: A Cost-utility Analysis of the CONDOR Study.

    Published in:
    Acta Dermato-Venereologica, 2020, v. 100, n. 12, p. 1, doi. 10.2340/00015555-3692
    By:
    • ATALAY, Selma;
    • VAN DEN REEK, Juul M. P. A.;
    • OTERO, Marisol E.;
    • NJOO, Marcellus D.;
    • MOMMERS, Johannes M.;
    • OSSENKOPPELE, Paul M.;
    • KOETSIER, Marjolein I.;
    • BERENDS, Maartje A.;
    • VAN DE KERKHOF, Peter C. M.;
    • GROENEWOUD, Hans M. M.;
    • DEN BROEDER, Alfons A.;
    • DE JONG, Elke M. G. J.;
    • KIEVIT, Wietske
    Publication type:
    Article
    8
    9
    10
    11